These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 22256863)

  • 1. Pharmacogenetics of alcoholism: a clinical neuroscience perspective.
    Ray LA; Courtney KE; Bujarski S; Squeglia LM
    Pharmacogenomics; 2012 Jan; 13(2):129-32. PubMed ID: 22256863
    [No Abstract]   [Full Text] [Related]  

  • 2. Preserved DNA from past clinical trials yields new information about a subtype of alcoholism.
    O'Brien CP
    Curr Psychiatry Rep; 2008 Oct; 10(5):375-6. PubMed ID: 18803909
    [No Abstract]   [Full Text] [Related]  

  • 3. An evaluation of mu-opioid receptor (OPRM1) as a predictor of naltrexone response in the treatment of alcohol dependence: results from the Combined Pharmacotherapies and Behavioral Interventions for Alcohol Dependence (COMBINE) study.
    Anton RF; Oroszi G; O'Malley S; Couper D; Swift R; Pettinati H; Goldman D
    Arch Gen Psychiatry; 2008 Feb; 65(2):135-44. PubMed ID: 18250251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Study suggests gene may predict success of therapies for alcohol dependence.
    Kuehn BM
    JAMA; 2011 Mar; 305(10):984-5. PubMed ID: 21386072
    [No Abstract]   [Full Text] [Related]  

  • 5. Predicting the effect of naltrexone and acamprosate in alcohol-dependent patients using genetic indicators.
    Ooteman W; Naassila M; Koeter MW; Verheul R; Schippers GM; Houchi H; Daoust M; van den Brink W
    Addict Biol; 2009 Jul; 14(3):328-37. PubMed ID: 19523047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New pharmacotherapies for alcohol dependence.
    Graham R; Wodak AD; Whelan G
    Med J Aust; 2002 Jul; 177(2):103-7. PubMed ID: 12098353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. COMBINE genetics study: the pharmacogenetics of alcoholism treatment response: genes and mechanisms.
    Goldman D; Oroszi G; O'Malley S; Anton R
    J Stud Alcohol Suppl; 2005 Jul; (15):56-64; discussion 33. PubMed ID: 16223057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The pharmacologic treatment of the alcohol dependence].
    Castro LA; Baltieri DA
    Braz J Psychiatry; 2004 May; 26 Suppl 1():S43-6. PubMed ID: 15729444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacotherapy for Adults with Alcohol Use Disorder.
    Salisbury-Afshar E
    Am Fam Physician; 2016 Jul; 94(2):155-7. PubMed ID: 27419333
    [No Abstract]   [Full Text] [Related]  

  • 10. Pharmacotherapy for alcohol dependence: anticraving medications for relapse prevention.
    Jung YC; Namkoong K
    Yonsei Med J; 2006 Apr; 47(2):167-78. PubMed ID: 16642544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Drugs against alcohol abuse].
    Mørland J
    Tidsskr Nor Laegeforen; 2006 Dec; 126(24):3268-9. PubMed ID: 17170774
    [No Abstract]   [Full Text] [Related]  

  • 12. [Good effect of drug therapy against alcoholism].
    Söderpalm B
    Lakartidningen; 2011 Oct 9-15; 108(45):2285-9. PubMed ID: 22242243
    [No Abstract]   [Full Text] [Related]  

  • 13. Prospects for a genomic approach to the treatment of alcoholism.
    O'Brien CP
    Arch Gen Psychiatry; 2008 Feb; 65(2):132-3. PubMed ID: 18250250
    [No Abstract]   [Full Text] [Related]  

  • 14. [Meta-analysis of pharmacological therapy with acamprosate, naltrexone, and disulfiram--a systematic review].
    Petrov I; Krogh J; Nordentoft M
    Ugeskr Laeger; 2011 Nov; 173(48):3103-9. PubMed ID: 22118653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Naltrexone for the treatment of alcoholism: clinical findings, mechanisms of action, and pharmacogenetics.
    Ray LA; Chin PF; Miotto K
    CNS Neurol Disord Drug Targets; 2010 Mar; 9(1):13-22. PubMed ID: 20201811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of alcohol dependence.
    Hanwella R; de Silva V
    Ceylon Med J; 2009 Jun; 54(2):63-5. PubMed ID: 19670554
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Neurobiological mechanisms and pharmacological treatment options for alcohol craving].
    Hillemacher T; Kornhuber J; Bleich S
    Fortschr Neurol Psychiatr; 2007 Jan; 75(1):26-32. PubMed ID: 17031777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacogenetics of naltrexone and disulfiram in alcohol dependent, dually diagnosed veterans.
    Arias AJ; Gelernter J; Gueorguieva R; Ralevski E; Petrakis IL
    Am J Addict; 2014; 23(3):288-93. PubMed ID: 24724887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Acamprosate and naltrexone: similar efficacy for relapse].
    Saitz R
    Rev Med Suisse; 2014 Dec; 10(455):2437. PubMed ID: 25752019
    [No Abstract]   [Full Text] [Related]  

  • 20. Treatment implications: using neuroscience to guide the development of new pharmacotherapies for alcoholism.
    Krishnan-Sarin S; O'Malley S; Krystal JH
    Alcohol Res Health; 2008; 31(4):400-7. PubMed ID: 23584013
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.